Viewing Study NCT01643603


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-29 @ 1:48 PM
Study NCT ID: NCT01643603
Status: TERMINATED
Last Update Posted: 2020-12-17
First Post: 2012-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module